These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5003599)

  • 1. [Do nitrites influence the blood lipid level?].
    Klein WW
    Med Klin; 1971 Dec; 66(50):1743-5. PubMed ID: 5003599
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood lipid patterns in ischemic heart disease and cerebrovascular diseases].
    Gaglio M; Caruso G; Milone A; Trovato GM; Vancheri FS
    Cardiologia; 1984; 29(3-4):203-10. PubMed ID: 6541939
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary research on the effects of administration of CoA on plasmatic lipids in humans].
    Arrigo F; Vitale D; Consolo F
    Clin Ter; 1974 Dec; 71(5):459-68. PubMed ID: 4452226
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipoprotein lipid alterations with cholestyramine administration.
    Jones RJ; Dobrilovic L
    J Lab Clin Med; 1970 Jun; 75(6):953-66. PubMed ID: 5421080
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-cholesterol (HDL-cholesterol) and other serum lipid fractions in subjects of low socioeconomic level with healed myocardial infarct].
    Giannini SD; Forti N; Di Rienzo F; Netto MP; Adler R; Almeida A
    Arq Bras Cardiol; 1983 Jun; 40(6):371-5. PubMed ID: 6667146
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic possibilities in blood circulatory and lipid metabolism disorders].
    Schneider H
    Z Allgemeinmed; 1971 Dec; 47(36):1916-8. PubMed ID: 5003958
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rapid changes in blood lipid parameters induced by glucuronyl glucosamine glycan sulfate in obese diabetic and hyperlipidemia patients].
    Ferlito S; La Spina E; Fichera C; Cultrera E; Patanè M; Ciulla P
    Arch Sci Med (Torino); 1982; 139(4):441-8. PubMed ID: 7168636
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the lipid pattern after administration of glucuronyl-glucosaminoglycan sulfate (3 GS) inpatients with with acute coronary syndromes].
    Gallone S; Mangiameli D; Vanaria F; Branca D; Lombardo D
    Boll Soc Ital Cardiol; 1975; 20(4):309-14. PubMed ID: 133704
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the effect of probucol on blood lipids].
    Giannini SD; Forti N; Ziliotto EE
    Arq Bras Cardiol; 1981 Feb; 36(2):139-42. PubMed ID: 7325835
    [No Abstract]   [Full Text] [Related]  

  • 11. Inadequate control of lipid levels in patients with a previous myocardial infarction.
    Ellis CJ; Zambanini A; French JK; Denton M; Johnson R; Patel H; White HD
    N Z Med J; 1998 Dec; 111(1079):464-7. PubMed ID: 9972199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum lipid determination after acute myocardial infarction].
    Wein M; Erbel R
    Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1619-20. PubMed ID: 9011492
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cynarin in the modern management of hyperlipemia].
    Pristautz H
    Wien Med Wochenschr; 1975 Dec; 125(49):705-9. PubMed ID: 820084
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of oxandrolone, protein anabolic steroid, on hyperlipemia: comparison between cases of hyperlipemia with or without diabetes].
    Okuno G
    Naika; 1972; 29(2):330-4. PubMed ID: 5015105
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipids in myocardial infarction (author's transl)].
    Riese Jordá HH; Sanchis-Bayarri Vaillant V
    Med Clin (Barc); 1981 Nov; 77(8):318-21. PubMed ID: 7334885
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of CRP preparation on serum lipids in patients with hyperlipidemia].
    Białkowska M; Szostak WB; Nowicka G; Szostak-Wegierek D
    Wiad Lek; 1993 May; 46(9-10):351-5. PubMed ID: 8236991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: a randomized, placebo-controlled study.
    Schrott HG; Knapp H; Davila M; Shurzinske L; Black D
    Am Heart J; 2000 Aug; 140(2):249-52. PubMed ID: 10925339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inborn errors of lipid metabolism. Effect of clofibrate on the level of blood lipids of patients with familial hyperlipoproteinemia (type 2, 3 and 4)].
    Sobra J; Heyrovský A; Sulc M; Horáková D
    Cas Lek Cesk; 1969 Aug; 108(36):1065-9. PubMed ID: 5807234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.